Shaolin Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
Shaolin Capital Management's TDAC Position: Q2 2026 in Review
Shaolin Capital Management reduced its Translational Development Acquisition Corp (TDAC) stake by 7.9% in Q2 2026, selling an estimated $185K and leaving 200,760 shares worth $2.15M. The position accounts for 0.1% of the portfolio, ranked #201.
Shaolin Capital Management first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.31M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Shaolin Capital Management held 200,760 shares of Translational Development Acquisition Corp worth $2.15M as of Q2 2026.
- Shaolin Capital Management sold 17,334 Translational Development Acquisition Corp shares in Q2 2026, an estimated $185K.
- Translational Development Acquisition Corp made up 0.1% of Shaolin Capital Management's portfolio in Q2 2026, its #201 holding.
- Shaolin Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
- Shaolin Capital Management's Translational Development Acquisition Corp position peaked at $2.31M in Q1 2026.
- 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.